Market Research, Market Size, Market Research Report, Market Share, Market Analysis, Market Growth,

Thursday, November 15, 2018

Pen Needles Market Growth Opportunity and Industry Forecast

The Pen Needles Market is expected to reach USD 2.81 Billion will be growing at a CAGR of 11.2%.

According to the new market research report Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) — Trends & Global Forecasts to 2021, published by MarketsandMarkets™. 
Don’t miss out on business opportunities in Pen Needles Market.
Speak to our analyst and gain crucial industry insights that will help your business grow:https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=75948613
A number of factors such as the favorable reimbursement environment and government support in selected countries; advantages of insulin pens over syringes and vials; technological advancements to minimize pain and needle anxiety; growing diabetic population; and conferences, meetings, and congresses to create pen needle awareness are expected to drive the growth of the Pen Needles Market during the forecast period.
In this report, the Pen Needles Market is segmented on the basis of type, needle length, therapy, mode of purchase, and region. Based on type, the Pen Needles Market is categorized into standard pen needles and safety pen needles. The standard pen needles segment is expected to account for the largest share of the Pen Needles Market in 2016. However, the safety pen needles segment is projected to grow at a higher CAGR during the forecast period.

Browse and in-depth TOC on “Pen Needles Market”

102 — Tables
53 — Figures
185 — Pages
View more detailed TOC @
Based on needle length, the Pen Needles Market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. The 8mm needle length segment is expected to account for the largest share of the market in 2016. However, the 4mm needle length segment is expected to grow at the highest CAGR during the forecast period.
On the basis of therapy, the Pen Needles Market is segmented insulin therapy, growth hormone therapy, and Glucagon-like Peptide-1 (GLP-1) therapy. The insulin therapy segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR in the forecast period.
Based on mode of purchase, the Pen Needles Market is segmented into retail and non-retail purchase. The retail purchase segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR during the forecast period.
Request for Free Sample Report @
Geographically, the global Pen Needles Market is divided into North America, Europe, Asia, and the Rest of the World (Latin America, Pacific countries, the Middle East, and Africa). Europe is expected to account for the largest share of the Pen Needles Market in 2016, followed by North America, Asia, and the Rest of the World. The Asian market is projected to grow at the highest CAGR and serves as a revenue pocket for companies offering pen needle products
Prominent players in the global Pen Needles Market include Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), Owen Mumford, Ltd. (U.K.), HTL-STREFA S.A. (Poland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), and Artsana S.p.a. (Italy).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact Us:
 
Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Wednesday, November 14, 2018

Cell Lysis Market Analysis 2018 Globally by Key Manufacturers, Countries, Type, Application and Forecast

The Global Cell Lysis Market is expected to reach USD 3.84 Billion, at a CAGR of 10.3%.

According to the new market research report Cell Lysis Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) — Global Forecasts to 2021, published by MarketsandMarkets™.
Don’t miss out on business opportunities in Cell Lysis Market.
The report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cell Lysis Market along with the estimates and forecasts of the revenue and market share analysis.
Speak to our analyst and gain crucial industry insights that will help your business grow:
The major factor driving the growth of this market are increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine
The report segments this market based on product, type of cell, end-users, and regions. Among the various product, the consumables segment is expected to account for the largest share of the market. The consumables market includes reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits. Enzymes segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of enzymes segment can be attributed to the increasing investments for cell-based research.
Browse and in-depth TOC on “Cell Lysis Market”
84 — Tables
41 — Figures
135 — Pages
View more detailed TOC @
On the basis of type of cell, the Cell Lysis Market is segmented into mammalian cells, microbial cells, and other cells. The mammalian cells segment is expected to account for the largest share of the global Cell Lysis Market in 2016. Rising aging population and increasing need for development of new cell therapies are the key factors propelling the growth of this market.
End-users, included in the Cell Lysis Market are research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment is expected to account for the largest share of the global Cell Lysis Market in 2016. High incidence of diseases and research investments in life sciences is driving the growth of this market.
Request for Free Sample Report @
Based on regions, the global Cell Lysis Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in aging population, and increasing government funding in North America.
Key players in the Cell Lysis Market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).
Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact Us:
 
Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Medical Automation Market 2018 Analysis, Key Players, Size, Growth Rate and Forecast

The Global Medical Automation Market over the forecast period expected to reach USD 55.03 Billion, at CAGR of 9.5 %.

According to the new market research report Medical Automation Market by Application (Diagnostics & Monitoring, Therapeutics, Lab & Pharmacy Automation, Medical Logistics & Training), End-User (Hospital, Diagnostic Center, Research Institute, Home/Ambulatory Care) — Global Forecast to 2020, published by MarketsandMarkets™.


On the basis of application, the medical automation market is divided into four major segments, namely, diagnostic and monitoring automation (automated imaging, automated image analysis, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and training (logistics automation and trainers). The therapeutic automation segment is estimated to hold the largest share of the global medical automation market in 2015. Increasing application of automated devices (such as defibrillators, surgical robots, surgical navigation systems, and automated medication systems) in therapeutics and rising incidences of various chronic diseases are driving the growth of this market segment.
Browse and in-depth TOC on “Medical Automation Market”
92 — Tables
53 — Figures
194 — Pages
View more detailed TOC @
On the basis of end users, the global medical automation market is divided into four segments, namely, hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.
A number of factors such as rising government support for medical automation, growing need for reproducibility and accuracy during medical procedures, investments by venture capitalists and collaborations to promote automated medical devices, and technological advancements are fueling the demand for automation in the healthcare industry. Additionally, increasing use of automation in various research activities, rising cost of labor, and rising number of research studies in emerging nations are some other factors contributing to the growth of the medical automation market. On the other hand, stringency of regulatory procedures leading to delay in product launches and high cost of automated solutions are the key factors hampering the growth of the global medical automation market.
Request for Free Sample Report @
North America is estimated to hold the largest share of the global medical automation market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 11.6% from 2015 to 2020. Presence of a large geriatric population; increasing prevalence of CVDs, diabetes, and cancer; rising number of clinical research activities; and growing government expenditure on healthcare and life sciences research are propelling the growth of the Asia-Pacific medical automation market.
Koninklijke Philips N.V. (Netherlands), Siemens AG, (Germany), General Electric Company (U.S.), Medtronic plc. (U.S.), Tecan Group Ltd. (Switzerland), Intuitive Surgical, Inc. (U.S.), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland) are some of the key players operating in the global medical automation market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact Us:
 
Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Tuesday, November 13, 2018

Regenerative Medicine Market Size, Share, Growth, Trend and Forecast

[137 Pages Report] The Regenerative Medicine Market is expected to reach USD 38.70 billion by 2021 from USD 13.41 billion in 2016 at a CAGR of 23.6%. 

The cell-based products are expected to dominate the global Regenerative Medicine Market.

Don’t miss out on business opportunities in Regenerative Medicine Market.


Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=65442579
The major factor driving the growth of this market, our government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.
Browse and in-depth TOC on “Regenerative Medicine Market”
87 — Tables
38 — Figures
137 — Pages
View more detailed TOC @
Based on therapy, the Regenerative Medicine Market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. The cell therapy segment is expected to account for the largest share of this market, increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies.
By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is expected to account the fastest growing market owing to increasing prevalence of cancer globally and rich product pipeline and increasing demand for cancer treatments.
Request for Free Sample Report @
Based on regions, the global Regenerative Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as technological advancement in the Regenerative medicine and rising incidences of chronic diseases and aging population.
Key players in the Regenerative Medicine Market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).
Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact Us:
 
Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Rehabilitation Equipment Market Analysis 2018 Globally by Key Manufacturers, Countries, Type, Application and Forecast

The global Rehabilitation Equipment Market is expected to reach 14.91 Billion by 2021 from USD 9.86 Billion in 2016, at a CAGR of 8.6% during the forecast period.
According to the new market research report Rehabilitation Equipment Market by Type (Mobility (Wheelchair, Assist Device), Body Support (Lift, Sling), Exercise (Upper, Lower Body), Living Aids (Reading, Writing)), Application (Physiotherapy, OT), End User (Hospital, Clinic, Home Care) — Forecasts to 2021, published by MarketsandMarkets™.
Don’t miss out on business opportunities in Rehabilitation Equipment Market.
This Research Report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=194775519
The growth of this market is mainly driven by factors such as growing incidence of disabilities resulting from non-communicable diseases, favorable healthcare reforms, and rapid growth in the geriatric population coupled with the rising prevalence of chronic diseases. However, a high cost & maintenance expense of rehabilitation equipment is the key factor that is expected to restrain the growth of this market to a certain extent.
In this report, the Rehabilitation Equipment Market has been segmented on the basis of type, application, end user, and region. Based on the type, the Rehabilitation Equipment Market is segmented into mobility equipment, body support devices, exercise equipment, and daily living aids. In 2016, the daily living aids segment accounted for the largest share of the market.
Browse and in-depth TOC on “Rehabilitation Equipment Market”
154 — Tables
31 — Figures
162 — Pages
View more detailed TOC @
On the basis of end user, the Rehabilitation Equipment Market is segmented into hospitals & clinics, rehabilitation centers, physiotherapy centers, and home care settings. In 2016, the hospitals & clinics segment accounted for the largest share of the Rehabilitation Equipment Market. This can be attributed to factors such as higher quality of treatment provided in hospitals and clinics, as opposed to other end-user segments, increasing sports injuries, the growth of the disabled and aged populations, and supportive reimbursement policies for hospital treatment.
Based on region, the Rehabilitation Equipment Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, Europe dominated the market, followed by North America. Factors such as supportive government initiatives for safe patient handling, growth in geriatric population, and the presence of a large number of players in Europe are driving the growth of the European Rehabilitation Equipment Market.
Request for Free Sample Report @
The Rehabilitation Equipment Market is fragmented in nature with several big and emerging players. This market is dominated by key players such as Invacare Corporation (U.S.), Medline Industries, Inc. (U.S.), Dynatronics Corporation (U.S.), Drive DeVilbiss Healthcare (U.S.), Changzhou Qian Jing Rehabilitation Co., Ltd. (China), Carex Health Brands (U.S.), Roma Medical (U.K.), Caremax Rehabilitation Equipment Co. Ltd. (China), GF Health Products, Inc. (U.S.), and HEMC (Hospital Equipment Manufacturing Company) (India).
Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact Us:
 
Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com

Monday, November 12, 2018

Global Antinuclear Antibody Test Market Size, Status, Overview and Future Forecast

According to the new market research report Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) — Forecast, published by MarketsandMarkets™.
The research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the ANA testing market, along with revenue estimates & forecasts and market share analysis.
The Global Antinuclear Antibody Test Market is expected to reach USD 1,476.1, at a CAGR of 12.4%, The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this market.
This report segments this ANA testing market based on products, diseases, techniques, end users, and regions. In the product's market, the assay kits & reagents segment is expected to account for the largest share. This segment is also expected to grow at the highest CAGR during the forecast period due to the growth in the number of reagent rental agreements and the increasing prevalence of autoimmune diseases worldwide.
Browse and in-depth TOC on “Antinuclear Antibody Test Market
73 — Tables
102 — Figures
166 — Pages
Based on techniques, the Antinuclear Antibody Test Market is segmented into three broad segment, namely, enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market owing to expanding applications of ANA in autoimmune disease testing and therapeutic drug level monitoring.
The Antinuclear Antibody Test Market’s end-user segments in this market include clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share in 2016, primarily due to the rising healthcare spending which has resulted in a growth in use of ANA testing products in hospitals. Based on region, the global Antinuclear Antibody Test Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). 
North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as rising geriatric population and increasing prevalence of autoimmune diseases.
Read More About “Antinuclear Antibody Test Market”:
Key players in the Antinuclear Antibody Test Market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.).